Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Chinese research team achieves new breakthroughs in autoimmune hepatitis treatment
On March 26, People’s Finance reported that a Chinese research team recently made significant progress in the treatment of autoimmune hepatitis. A joint research team from Qilu Hospital of Shandong University and the School of Pharmacy of Shandong University proposed a new method based on in vivo cell reprogramming, providing new ideas for the treatment of autoimmune diseases. The related research results have been published in the international academic journal “Cell-Stem Cell.” (Xinhua News Agency)